Sunday, December 28, 2025 | 09:25 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sohini Das

Sohini Das

Sohini Das

Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.

Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.

Email
Twitter
LinkedIn

Page 38 - Sohini Das

Fierce competition among new drug brands for share of India market

The competitive intensity is high between brands, at a time when volume growth in the domestic pharma market is on a slow lane

Fierce competition among new drug brands for share of India market
Updated On : 07 Aug 2023 | 11:42 PM IST

Metropolis Healthcare eyes 60% revenue from B2C business in next 2-3 years

The diagnostic player has also taken price hikes in the range of 4-5 percent in the last three years

Metropolis Healthcare eyes 60% revenue from B2C business in next 2-3 years
Updated On : 07 Aug 2023 | 12:12 AM IST

Won't invest in RBL further unless it sees 'compelling value': M&M

M&M Board had approved a stake buy of up to 4.5 per cent in RBL Bank

Won't invest in RBL further unless it sees 'compelling value': M&M
Updated On : 04 Aug 2023 | 11:32 PM IST

M&M Q1 PAT up 60% to Rs 3,508 cr on strong auto performance, revenue up 19%

The board has recommended a dividend of Rs 16.25 per share

M&M Q1 PAT up 60% to Rs 3,508 cr on strong auto performance, revenue up 19%
Updated On : 04 Aug 2023 | 11:29 PM IST

Industry, patient groups want draft drugs and medical devices Bill recalled

Seek a separate 'Medical Devices Act' distinct from the drug regulations Bill

Industry, patient groups want draft drugs and medical devices Bill recalled
Updated On : 04 Aug 2023 | 9:54 AM IST

Sun Pharma Q1 PAT dips 2% on one-time expense; US revenues up 12%

Sun Pharma's stock ended flat at Rs 1140.85 on the BSE

Sun Pharma Q1 PAT dips 2% on one-time expense; US revenues up 12%
Updated On : 03 Aug 2023 | 10:29 PM IST

Temasek Holdings funding drives M&M EV arm valuation to Rs 80,000 crore

Singapore investment firm to hold 1.49-2.97% stake in EV business

Temasek Holdings funding drives M&M EV arm valuation to Rs 80,000 crore
Updated On : 03 Aug 2023 | 10:14 PM IST

Mankind Pharma PAT up 66% in Q1 to Rs 494 crore on revenue growth

Juneja also highlighted a 43 per cent YoY increase in Ebitda as a positive outcome of the company's previous initiatives to improve profitability

Mankind Pharma PAT up 66% in Q1 to Rs 494 crore on revenue growth
Updated On : 02 Aug 2023 | 9:06 PM IST

Proxy advisors, analysts favour cash deal to acquire Suzuki Gujarat plant

Maruti says it wants to have multiple powertrain production at multiple locations under single control

Proxy advisors, analysts favour cash deal to acquire Suzuki Gujarat plant
Updated On : 01 Aug 2023 | 10:06 PM IST

Maruti to acquire Suzuki Motor Corp's Gujarat plant to boost efficiency

Maruti will take over EV production at Gujarat site, replacing Suzuki Motor Corp

Maruti to acquire Suzuki Motor Corp's Gujarat plant to boost efficiency
Updated On : 01 Aug 2023 | 9:37 AM IST

Allegra, Dolo-650 among 300 pharmaceutical brands to have QR codes

Batches manufactured on and after August 1 will have QR codes printed on the packaging of the selected 300 brands

Allegra, Dolo-650 among 300 pharmaceutical brands to have QR codes
Updated On : 31 Jul 2023 | 10:34 PM IST

Big pharma firms shift tack, look to bet on trade generics as volumes dip

It is the fastest growing segment in IPM with a 25% CAGR

Big pharma firms shift tack, look to bet on trade generics as volumes dip
Updated On : 30 Jul 2023 | 10:49 PM IST

BPEA EQT set to acquire 60% stake in Indira IVF for Rs 6,000 crore

Boston, Massachusetts-based TA Associates is selling its 47 per cent stake in Indira IVF

BPEA EQT set to acquire 60% stake in Indira IVF for Rs 6,000 crore
Updated On : 29 Jul 2023 | 12:17 AM IST

Wockhardt says NBFC Guardian Finance wrongfully invoked 2 mn shares

Some members of the promoter group had pledged certain shares of Wockhardt with Guardian Finance to avail loan

Wockhardt says NBFC Guardian Finance wrongfully invoked 2 mn shares
Updated On : 28 Jul 2023 | 11:39 PM IST

Eye-flu to stomach ailments: Major cities grappling with monsoon illnesses

Mumbai doctors say that in the last one or two weeks there has been a 20-25 per cent surge in such cases, and most of the patients are children

Eye-flu to stomach ailments: Major cities grappling with monsoon illnesses
Updated On : 27 Jul 2023 | 11:22 PM IST

Blackstone, Baring in race to acquire up to 20% stake in pharma firm Cipla

Cipla shares closed 9.6 per cent up on Thursday to Rs. 1,175

Blackstone, Baring in race to acquire up to 20% stake in pharma firm Cipla
Updated On : 27 Jul 2023 | 11:11 PM IST

Never again will India be starved of essential drugs, says Cipla founder

As of July 27, Cipla's market cap stands at Rs 94572 crore

Never again will India be starved of essential drugs, says Cipla founder
Updated On : 27 Jul 2023 | 10:10 PM IST

Syngene's playbook: 50% revenue from contract manufacturing in 2-3 years

Acquisition of Stelis facility saves $15 million in capex in FY24

Syngene's playbook: 50% revenue from contract manufacturing in 2-3 years
Updated On : 27 Jul 2023 | 7:47 PM IST

M&M picks up 3.5% stake in RBL Bank for Rs 417 cr, eyes to acquire more

Company says it may consider further investment in the bank to raise its holding up to 9.9%

M&M picks up 3.5% stake in RBL Bank for Rs 417 cr, eyes to acquire more
Updated On : 26 Jul 2023 | 11:34 PM IST

Dr Reddy's Laboratories Q1 PAT up 18% to Rs 1,402 cr on India, Russia biz

With cash surplus of Rs 4980 crore, pharma major looking at inorganic opportunities

Dr Reddy's Laboratories Q1 PAT up 18% to Rs 1,402 cr on India, Russia biz
Updated On : 26 Jul 2023 | 11:31 PM IST